(All fields required)
Please enter a valid email.
Please enter your name.
Research Study to Learn More about What Causes LupusThis is a research study to determine the cause of lupus and to improve understanding of the disease. The study specifically seeks to help find the genes that are involved in lupus development and to learn how they work differently in people with and without the condition. Studying lupus at the genetic level to determine its causes may lead to advances that will improve how it is diagnosed and treated. Contact Nicolette Barbour, clinical research assistant, 513-803-3307, firstname.lastname@example.org.
Children and Teens 8 to 18 Needed for Lupus Outcomes Research Study The purpose of this research study is to support the Pediatric Patient Reported Outcomes Measurement Information System (PROMIS) Item Banks for pediatric systematic lupus erythematosus (pSLE) and compare its performance to other quality of life measures previously proven for pSLE. Contact Alexa Greenler, Alexandria.Greenler@cchmc.org, 513-803-4328.
Lupus DatabaseThe purpose of this study is to create an electronic database of patients diagnosed with systemic lupus erythematosus (SLE). This database will serve as a resource list of patients to contact for clinical trials of new medicines. People listed in the database will be individually contacted about trials they may be eligible for and then have the choice of whether or not to participate. Data to be collected include name, date of birth, address, phone number, clinical information from medical records and from questionnaires completed by physicians and patients. No blood tests are required. Contact Jessica Hummel, email@example.com, 513-803-2115.
Puberty StudyThis study addresses the question of how hormonal changes in puberty affect lupus in girls who have been diagnosed with lupus. The study includes visits every 3 months over an approximate three-year period, blood draws and urine samples. Physical examinations are performed and questionnaires completed. Contact Jessica Hummel, firstname.lastname@example.org, 513-803-2115.
Ovary Protection Medication StudyThe purpose of this study is to determine the safety and effectiveness of an ovary protection medication (triptorelin), and its dosage and the time necessary to suppress ovaries to protect them against harmful effects of chemotherapy used in treating lupus. Contact study coordinator: Shannen Nelson, email@example.com, 513-636-5484
Biomarkers for Systemic Lupus Erythematosus (SLE) Renal Disease This study is looking at why the kidneys are more likely to be affected in SLE that starts in childhood than in SLE first diagnosed in adults. Data will be gathered from medical records and questionnaires. No experimental medicines, treatments or procedures are involved, although blood and urine samples are required. Study participants will need to visit the Lupus Clinic 7 times over a period of 18 months. Contact study coordinator Jamie Eaton, firstname.lastname@example.org, 513-636-0395.
Download the Urinary Biomarkers May Differentiate Between Children with ISN/RPS Class IV versus Class V of Lupus Nephritis (LN) Abstract.
Download Candidate Urinary Biomarkers May Predict Histological Features On Lupus Nephritis (LN) Biopsy Abstract.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2013 Cincinnati Children's Hospital Medical Center